Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Hopes rise for coronavirus drug remdesivir

Despite conflicting studies, results from largest trial yet show the antiviral speeds up recovery, putting it on track to become a standard of care in the United States.
  1. Heidi Ledford
    View author publications

    You can also search for this author in PubMed  Google Scholar

An experimental drug — and one of the world’s best hopes for treating COVID-19 — could shorten the time to recovery from coronavirus infection, according to the largest and most rigorous clinical trial of the compound yet. On 1 May, the US Food and Drug Administration (FDA) granted an ‘emergency use authorization’ for clinicians to use the drug, called remdesivir, which is administered intravenously, in hospitals for people with severe COVID-19.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

doi: https://doi.org/10.1038/d41586-020-01295-8

Updates & Corrections

  • Update 04 May 2020: This story has been updated to note that on 1 May US regulatory authorities granted remdesivir ‘emergency use’ authorization for use in people with severe COVID-19.

References

  1. Wang, Y. et al. Lancet https://doi.org/10.1016/S0140-6736(20)31022-9 (2020).

    Article  Google Scholar 

  2. Wang, M. et al. Cell Res. 30, 269–271 (2020).

    Article  PubMed  Google Scholar 

  3. Cao, B. et al. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2001282 (2020).

    Article  Google Scholar 

  4. Sheahan, T. P. et al. Sci. Transl. Med. 12, eabb5883 (2020).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links